More about Avacta
Avacta Group Plc Ord 10P is listed on the London Stock Exchange trading with ticker code AVCT.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £28,363m, with approximately 249m shares in issue. Over the last year, Avacta share price has been traded in a range of 197, hitting a high of 210.50, and a low of 13.50.
Avacta Group Plc, officially known as Avacta Group Plc Ord 10P was formed in April of 2003, making the company seventeen years old. The company filed its latest accounts on 31st July 2014, showing a turnover of approximately 3.18 million GBX with gross profits of 2.04 million, or 0.0082 per issued share, and a pre-tax profit margin of -64.25%. Avacta Group Plc currently has 6 directors, and has had 13 previous directors over the last 17 years. In the last set of accounts produced by Kpmg Llp, the company showed 2.84 million paid in salaries to the 71 staff (average wage of 40 thousand), with the directors receiving an average 57 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Avacta Group Plc to have a net worth of 12.55 million, with 11.48 million held in cash.
Avacta is in the Medicine and Biotech Research sector.
 | Tungsten Corp (TUNG.L) |  |
 | Tristel (TSTL.L) | |
 | E-therapeutics (ETX.L) | |
 | Christie (CTG.L) | |
 | Immupharma (IMM.L) | |
| Tristel (TSTL.L) | |
 | Serica (SQZ.L) | |
 | Palace Capital (PCA.L) | |
 | Eckoh Technologies (ECK.L) | |
 | Portmeirion (PMP.L) | |
Avacta Share Information
| Volume | 2m |
|---|---|
| Currency | GBX |
| Shares in Issue | 249m |
| Market Capitalisation | £28,363m |
| 52 Week High | 210.50 |
| 52 Week Low | 13.50 |